News Focus
News Focus
icon url

georgejjl

10/29/23 2:33 PM

#437499 RE: Investor2014 #437498

You will see that the regulatory agencies (FDA, EMA, TGA, etc,) will approve blarcamesine for both Alzheimer's disease and Rett syndrome treatment. These agencies will allow for maximum efficacy with minimal side effects.

GOD bless,
Bullish
Bullish